ALA 2.63% 19.5¢ arovella therapeutics limited

Ann: Anagrelide Project Update, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,025 Posts.
    lightbulb Created with Sketch. 782
    Dpowell: Simplified: the last CR was done at 2.5 cents. Either that was 'too low' or it was correctly priced. IF it is the latter, then the share-price right now is WAY ABOVE that CR pricing - hence kind of 'over-priced'.
    Moreover, normally the share-price after a CR tends to creep back down towards the CR pricing...
    Hence, JIMHO, the SUD share-price could easily re-treat into the 3 - 4 cents territory.

    As mentioned, I could be completely wrong. Comments most welcome!!!

    wasa

    PS: As a long-term shareholder of EMS/SUD, I am not from any "other side", i.e. not 'down-ramping' but would like to see SUDA finally become a success story.... I hope to still live that long, however.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.